1 / 12

Consumption of antibiotics before and after sales regulations in Chile, Colombia and Venezuela

Consumption of antibiotics before and after sales regulations in Chile, Colombia and Venezuela. Juan Jose Herrera Patiño, Yared Santa-Ana-Tellez, , Anahi Dreser, Ralph Gonzales, Veronika J. Wirtz Center for Health Systems Research & Center of Evaluation and Survey Research,

faxon
Download Presentation

Consumption of antibiotics before and after sales regulations in Chile, Colombia and Venezuela

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Consumption of antibiotics before and after sales regulations in Chile, Colombia and Venezuela Juan Jose Herrera Patiño, Yared Santa-Ana-Tellez, , Anahi Dreser, Ralph Gonzales, Veronika J. Wirtz Center for Health Systems Research & Center of Evaluation and Survey Research, National Institute of Public Health, Mexico

  2. Background • One of the main drivers of antimicrobial resistance is antibiotic consumption. • To combat resistance the WHO has recently recommended that sales restrictions of antibiotics should be reinforced. • Several middle-income countries have enforced sales restriction of antibiotics (AB) • Chile in 1999, • Colombia in 2005 • Venezuela in 2006. • Enforcement may have an impact on use of antibiotics, but little systematic evaluation of its effect over time.

  3. Study aim and methods To analyze the change in consumption of antibiotics (AB) in Chile, Colombia and Venezuela between 1997 and 2010. Design:Interrupted time series analysis of systemic AB consumption for Chile, Colombia and Venezuela and one other LA country (Mexico) as control group between 1997 and 2010. Setting: Market intelligence data of AB sales aggregated at national level WHO ATC code J01 quarterly between 1997 and 2010. Study Population:The total AB consumption and Stratification by a) broad-spectrum therapeutic groups: quinolones, macrolides/ lincosamides and third generation cephalosporins. b) narrow spectrum groups: penicillin, trimethoprim-sulfamethoxazole, and first and second generation cephalosporins.

  4. Methods (cont.) Interrupted time series with control group Outcome:AB sales aggregated by country, expressed in defined daily dose per 1,000 inhabitants per day (DDD). Intervention: • Venezuela: sale regulation only included the broad spectrum groups • Chile and Colombia: sale regulation for all AB • Control country: no sales regulation implemented Data analysis: • AB consumption change • Trend change У(t)= β0 + β1T+ β2 D + β3 P+ β4G + β5GT+ β6 GD + β7GP + ε(t)

  5. Results (1): Sales restrictions varied in impact on AB between intervention countries DDD per 1 000 inhabitants per day

  6. Results (2): Chile with the greatest impact of sale restrictions on AB consumption

  7. Results (3): Sales restriction had a small impact on penicillin consumption in Columbia

  8. Results (4): no significant change in consumption in Venezuela after sales restriction

  9. Limitations • Retail sales data does not represent the entire pharmaceutical market of the country • Independent validation of data sources such as market intelligence data is relevant but not possible in many cases • Quantitative analysis can not explain the causes for the different impact of the intervention but can help to generate hypothesis • Decrease in AB consumption does not necessarily indicate more adequate use

  10. Conclusions • The sales restrictions of antibiotics in these three countries had different impact on the sales volume. • Qualitative research is needed to analyze the underlying causes for the different effects of policies restricting sales of antibiotics. • Continuous reinforcement of sales restrictions is necessary to have a prolonged impact.

  11. Acknowledgements: • IMS Health for data provision • Jose Miguel Torres Gonzalez from Colegio de Mexico for provision of feedback on the statistical analysis Conflicts of interest: • Authors declare no conflicts of interest Funding sources: • This study was funded by the National Institute of Public Health (INSP), Mexico

More Related